Home
Solutions
Products
Pricing
Resources
Request Demo
Start Free
Menu Search Account

LegiStorm

Get LegiStorm App Visit Product Demo Website
» Get LegiStorm App
» Get LegiStorm Pro Free Demo
StateStorm

Weekly Updates

LegiStorm is constantly adding new information on the people, places and reports in our database. In the past week, LegiStorm added:

  • 1865 new people
  • 34 new organizations
  • 622 new photos
  • 1247 job history records for people in our database
  • 518 education records for people in our database
  • 2209 contact addresses, emails and URLs (LinkedIn, Facebook, etc.)
  • 198 new policy reports
  • 12 new trips to our privately funded travel database
  • 921 new personal financial disclosures
  • 27459 new press releases
  • 30 new town halls

Caught Our Eye Rss

» More from Caught Our Eye
» More from our DevBlog

H.R. 1734, TRANQ Research Act (CBO Report for Congress)

Premium   Download PDF Now (2 pages)
Congress 118th
Date Requested March 29, 2023
Requested By House Committee on Science, Space, and Technology
Date Sent May 5, 2023
Description:
H.R. 1734 would require the National Institute of Standards and Technology (NIST) to research processes and techniques to identify and differentiate illicit drugs containing xylazine and other novel synthetic opioids and reduce the time necessary to analyze those drugs. In addition, the bill would require NIST to coordinate opportunities for graduate and post-graduate research on detecting and identifying those drugs. Finally, H.R. 1734 would require the agency to report to the Congress on the bill’s implementation not later than one year after enactment. To carry out that research, the agency would need to enhance its capabilities for analyzing such drugs with specialized equipment and more employees to study those issues. NIST also would need to establish public, private, and academic partnerships to generate strategies and best practices for the safe handling, transport, and analysis of such drugs.

« Return to search CBO reports

HomeAbout Us Contact UsPrivacy PolicyTerms of UseJoin Us
© LegiStorm
LegiStorm
2101 L St. NW, Suite 300
Washington, DC 20037
(202) 360-4172 / congress@legistorm.com